---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-22-000145"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2022-07-28T23:59:59+00:00"
generated_at: "2026-06-24T07:16:35.825148+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Dexcom authorizes $700M share repurchase program through June 30, 2023

## Summary
- Board committee approved a share repurchase program for up to $700M of outstanding common stock.
- Repurchase period ends no later than June 30, 2023; timing depends on market conditions.
- Repurchases may be made on open market or in privately negotiated transactions; no obligation to repurchase any amount.
- Program may be extended, modified, suspended, or discontinued at any time.

## SEC filing metadata
- accession: 0001093557-22-000145
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2022-07-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355722000145/0001093557-22-000145-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355722000145/dxcm-20220726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-22-000145
- JSON: https://secwatch.observer/filing/0001093557-22-000145.json
- Plain text: https://secwatch.observer/filing/0001093557-22-000145.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.